The biodiversity hypothesis and allergic disease: world allergy organization position statement by Haahtela, T. et al.
POSITION ARTICLE AND GUIDELINES Open Access
The biodiversity hypothesis and allergic disease:
world allergy organization position statement
Tari Haahtela1*, Stephen Holgate2, Ruby Pawankar3, Cezmi A Akdis4, Suwat Benjaponpitak5, Luis Caraballo6,
Jeffrey Demain7, Jay Portnoy8, Leena von Hertzen1, and WAO Special Committee on Climate Change
and Biodiversity
Abstract
Biodiversity loss and climate change secondary to human activities are now being associated with various adverse
health effects. However, less attention is being paid to the effects of biodiversity loss on environmental and
commensal (indigenous) microbiotas. Metagenomic and other studies of healthy and diseased individuals reveal
that reduced biodiversity and alterations in the composition of the gut and skin microbiota are associated with
various inflammatory conditions, including asthma, allergic and inflammatory bowel diseases (IBD), type1 diabetes,
and obesity. Altered indigenous microbiota and the general microbial deprivation characterizing the lifestyle of
urban people in affluent countries appear to be risk factors for immune dysregulation and impaired tolerance. The
risk is further enhanced by physical inactivity and a western diet poor in fresh fruit and vegetables, which may act
in synergy with dysbiosis of the gut flora. Studies of immigrants moving from non-affluent to affluent regions
indicate that tolerance mechanisms can rapidly become impaired in microbe-poor environments. The data on
microbial deprivation and immune dysfunction as they relate to biodiversity loss are evaluated in this Statement of
World Allergy Organization (WAO). We propose that biodiversity, the variability among living organisms from all
sources are closely related, at both the macro- and micro-levels. Loss of the macrodiversity is associated with
shrinking of the microdiversity, which is associated with alterations of the indigenous microbiota. Data on
behavioural means to induce tolerance are outlined and a proposal made for a Global Allergy Plan to prevent and
reduce the global allergy burden for affected individuals and the societies in which they live.
Keywords: Allergy plan, Biodiversity, Civilization disease, Epigenetics, Immune dysfunction, Microbiota, Microbiome,
Urbanization
Introduction
Biodiversity loss is a global concern with a variety of
possible adverse consequences for humanity. The rea-
sons for this loss are complex and are in large part due
to the consequence of industrialization, pollution and
utilization of chemicals, which impact the environment
and the microorganisms with which humans have lived
since time immemorial. In recent years, attention has
been paid to the potential health effects of this altered
biosphere. Indeed, the two global megatrends, one in the
state of biodiversity and the other in the prevalence of
mucosal inflammatory diseases, may be more closely
linked than is commonly recognized (Figure 1).
Inflammation is a cardinal feature of asthma and al-
lergic diseases, autoimmune diseases, and many forms
of cancer [1], but more recently less tangible associa-
tions have been linked to these trends such as an
increased incidence of depression associated with
inflammatory markers [2]. Thus far, the increase
in the prevalence of inflammatory disorders is a
phenomenon largely restricted to the developed
world, while such disorders are still uncommon
among populations in non-affluent regions, i.e. those
regions, which still have more traditional non-urban
lifestyles [3,4]. Adoption of cultural patterns and nu-
tritional habits from affluent countries, together with
declining frequency and severity of intestinal parasitic
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infections, are rapidly changing the allergy trends upwards
also in many developing countries [5]. Not unexpectedly,
loss of traditional cultures and loss of biodiversity are
likely linked and as such, driven by shared factors such as
increased urbanization, commercialization and widespread
use of chemicals [6].
Previous studies reveal that microbe-rich environments
confer protection against allergic and autoimmune dis-
eases [3,4,7], but it is likely that declining biodiversity is
more generally responsible for human immune dysfunc-
tion. Hanski et al. [8] showed recently, that compared with
healthy adolescents the atopic individuals had lower envir-
onmental biodiversity – in the form of species richness of
native flowering plants and in the land use type – in the
surroundings of their homes. The atopic adolescents also
had significantly lower generic diversity of Gram-negative
gammaproteobacteria on their skin. Furthermore, the
abundance of the genus Acinetobacteria on the skin was
positively correlated with the peripheral mononuclear cell
expression of IL-10, a key anti-inflammatory cytokine in
immunological tolerance. Gammaproteobacteria are com-
mon in the soil, but are particularly dominant in above-
ground vegetation, such as flowering plants.
The line of evidence that the declining biodiversity of
plants, animals, and their natural habitats is associated
with changes in the interactions between humans and
microbes, and that these interactions might be causally
related to the increasing prevalence of asthma and allergy
as well as other inflammatory disorders, is reviewed in
this paper.
Focus on environmental factors
Irrespective of major efforts to clarify the genetic causes,
which predispose to the onset of asthma and allergic
diseases, the results remain rather modest [9], underscor-
ing the genetic complexity of these multi-trait diseases.
Increased attention is now focused on critical environmen-
tal factors in the search for the origins of these diseases.
Studies of immigrants, epigenetic studies and mapping of
the gut microbiota have provided compelling evidence that
the environment can fundamentally modulate immune
function in humans (Table 1). Poorly developed or broken
immune tolerance plays a role in the pathogenesis of many
diseases such as allergy and asthma, autoimmunity, cancer,
chronic infections, abortions [10].
Living in urban environments with higher exposure to
chemicals and with reduced green space with the conse-
quence of limited plant, animal and microbial life is
associated with immune dysfunction and impaired tole-
rance in humans [11]. Reduced contact with nature and
environmental microbiota appears to be linked with a
range of civilization diseases, including allergy and type
1 diabetes [12]. Of considerable concern is that these
chronic inflammatory diseases are becoming increas-
ingly prevalent in low and middle income countries in
parallel to their improving economic development and
adoption of western-type urbanization. It is possible that a
more biodiverse exposure confers more protection, not
only against infectious diseases [13], but also against
chronic inflammatory (and possibly malignant) diseases.
Novel methodologies now allow accurate determi-
nation of microbial communities in various ecosystems.
Despite this advance in technology, hardly anything is
known about the interactions between environmental and
indigenous microbiotas. How are reduced biodiversity and
the change in the micro-organism profile found in urban
and more affluent environments reflected in the indigenous
human microbiotas? What are the effects of biodiversity
loss of plants and animals on environmental microbiota?
We propose that biodiversity at the level of macrobiota
and microbiota are interrelated in that biodiversity loss of
the former is likely to be associated with loss of diversity
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Figure 1 Two global megatrends in biodiversity and public health. (a) Declining biodiversity (percentage change) since 1970 as measured
by two indices. WPSI=Waterbird Population Status Index; LPI=Living Planet Index [14]. (b) Increasing trends in the prevalence of inflammatory
civilization diseases, asthma and allergic rhinitis among military conscripts in 1966-2003 [165] as an example (modified from ref. [14]).
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of the latter [14]. Moreover, biodiversity loss leads to
reduced interaction between environmental and human
microbiotas. This in turn may lead to immune dysfunction
and impaired tolerance mechanisms in humans.
Concepts of biodiversity
By definition, biodiversity is ‘the variability among living
organisms from all sources, including, inter alia, terres-
trial, marine and other aquatic ecosystems and the eco-
logical complexes of which they are part. This includes
diversity within species, between species and of ecosys-
tems’ [15]. In practice, the key elements of biodiversity in-
clude genetic diversity of populations and species; the
richness of local and global species; the spatial extent and
the state of natural habitats; and the functioning of ecosys-
tems that provide various essential services to mankind.
The year 2010, the United Nations’ International Year
of Biodiversity, was to be the turning point for biodiver-
sity decline, but a recent comprehensive report shows
that this target has not yet been met; the rate of bio-
diversity loss does not show signs of decreasing, and
worryingly, the indicators which reflect the various pres-
sures on biodiversity continue to increase [16]. For
example, one-third of the sufficiently well-defined spe-
cies of animals and plants are currently classified as
threatened (56000 species) [17].
Although the Convention of Biological Diversity [15]
is primarily concerned with plants and animals, biodiver-
sity also includes micro-organisms, which are less visible
but comprise the bulk of living matter on our Earth [18].
Biodiversity, according to the definition, concerns both
environmental and commensal microbiota. Thus far,
little attention has been paid to the biodiversity of en-
vironmental microbiota.
Biodiversity and human health
There is a rich literature to demonstrate that natural
environments are of vital importance to the physical and
mental health of humans [19], and as a consequence,
biodiversity should be integrated into the conventional
measures of well-being and recognized as a global public
good requiring conscious collective choices [20].
A recent large study found that the annual preva-
lence rate of most disease clusters was lower in envi-
ronments where people were living with more green
space (10% or more than the average) within a 1 km
radius. This effect was most pronounced for depression
and anxiety, but also significant for asthma/COPD,
diabetes and coronary heart disease [21]. Green space,
including forests and natural areas as well as parks,
may act as a buffer between stressful life-events and
health [22]. Aligned to this concept, better self-reported
health and lower stress scores also have been reported
to be inversely associated with the distance to green
space [23].
A meta-analysis of 10 intervention studies reveal that
‘green exercise’ (activities in natural environments), even
of short duration, significantly improved the physical
and mental health [24]. Of importance, physical activity
in a natural environment versus other settings, appears
to have more beneficial health effects [25].
Several on-going studies have examined the health effects
of forests [26]. Compared with urban settings, forest
environments are associated with lower cortisol level,
lower pulse rate and blood pressure as well as with higher
parasympathetic and lower sympathetic nerve activity in
healthy individuals [27]. It is increasingly recognized
that exposure to nature, and forest environments in par-
ticular has the potential to substantially improve human
health [26].
Table 1 Evidence of the immunomodulatory capacity of the living environment in humans
Evidence from Altered susceptibility to References
Immigrant studies Allergic diseases [74,75,77,78]
Type 1 diabetes [73]
Multiple sclerosis [76]
Obesity, type 2 diabetes [79]
Depression [80]
Cancers [81]
Epigenetic studies
Microbial deprivation Allergic diseases [111,117,118]
Air pollution Asthma deterioration [119]
Studies on the gut and skin microbiota
Microbial deprivation, altered composition Allergic diseases [8,51-54]
Data on altered susceptibility to inflammatory diseases are for immigrants moving from less affluent to affluent countries, except in ref [76].
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The health effects of natural environments are obvious,
but difficult to examine experimentally. Accumulating
evidence underlines the critical role for micro-organisms
in the normal development and maintenance of mucosal
integrity and tolerance [28,29]. Urbanization and general
loss of biodiversity, combined with sedentary indoor life-
styles have been a principle driving factor leading to
microbial deprivation [14,30] and may play a significant
role in the epidemics of inflammatory diseases. Neverthe-
less, more data and better understanding of the relevant
mechanisms underlying the ‘nature effect’ at the cellular
and molecular levels are necessary.
Immune regulation – mechanisms of tissue integrity and
homeostasis
Various immune cells must interact with microbes for
normal development and function. Protective mechan-
isms against inflammatory diseases involve the activation
of the innate and regulatory networks by continuous
exposure to microbial components via the skin, gut and
respiratory tract. Humans have evolved with these micro-
organisms, which do not elicit defensive immune responses,
but rather induce immune regulatory circuits. A suddenly
reduced abundance or diversity of these micro-organisms,
previously ubiquitous, may have led to failures to regu-
late and restore appropriate immune and inflammatory
responses [11].
Signaling via Toll-like receptors (TLRs) and other
conserved pattern-recognizing molecules [31,32] that
are present on/in various cells play a decisive role, not
only in host defense against pathogens, but also to main-
tain epithelial cell homeostasis and tissue repair [28]. This
apparently universal phenomenon has been shown in
various tissues and occurs in wound healing [33]. Evi-
dence from mice highlights the role of TLR stimulation
to confer protection against inflammatory conditions,
supporting the epidemiological studies of human popu-
lations living in a microbe-rich environment. The effects
were mediated by induction of regulatory circuits [34,35]
and by stimulating innate immune mechanisms in epithe-
lial cells [36].
Alterations in human microbiota – implications for
immune dysregulation and inflammatory disorders
A fundamental role for micro-organisms in human health,
whether indigenous or environmental, is becoming increas-
ingly evident. Commensals are no longer considered as
passive bystanders or transient passengers, but increasingly
as active and essential participants in the development and
maintenance of barrier function and immunological toler-
ance [37]. They are also involved in the programming of
many aspects of T cell differentiation in co-operation with
the host genome [29]. Mounting evidence also shows that
alterations in the indigenous microbiota correlate with
inflammatory disease states [38]. The indigenous flora may
not only comprise bacteria and fungi, but also viruses and
microscopic protozoans, although hardly any data on the
latter are available.
This paper focuses on the gut and skin bacterial flora,
the two microbiotas that have been studied in greatest
detail. Although the current literature is dominated by
data about the gut flora to maintain immune tolerance
and health, the on-going metagenomic studies may dem-
onstrate a significant role for microbiotas at other sites,
including the respiratory tract [39] and skin [40].
Gut microbiota and inflammatory diseases
The human gut flora is thought to be an essential ‘organ’,
which not only provides nutrients, but also regulates
epithelial development and orchestrates innate immun-
ity [41]. The gut community is dominated by only two
phyla, Firmicutes and Bacteroidetes, and to a lesser ex-
tent by Acinobacteria and Proteobacteria, even though
the populations of bacteria in the gut are huge and
diverse at both the genus and species levels [41-43].
Recent metagenomic data indicate that any one individ-
ual harbours an assemblage of at least 160 species,
which are partly shared with other individuals. The total
number of bacterial species identified in a sample of 124
Europeans was 1000 to 1150 [44], suggesting a rather
distinct composition of flora present in each individual.
The microbiota is variable and shows temporal fluctu-
ation in early life. When a steady state is reached, the
composition of the gut flora remains relatively stable
over time, providing that no major changes in lifestyle or
environment occur [45]. Early environmental exposures
are thus considered the key determinant of adult gut
microbiota [46], as is the type of diet consumed [47-50].
Clues about the influence of environmental factors on
the development of the gut microbiota have been
obtained from studies of infants in Estonia and Sweden
and provide some of the first evidence that the compos-
ition of gut microflora between non-western and western
children in early life differs and that these disparities could
be associated with the manifestation of allergic diseases in
later life [51-53]. Using novel molecular-based methods, a
Swedish study revealed that a more diverse gut microbiota
early in life is associated with protection against allergy at
the age of 5 years [54].
Dysbiosis, the reduced diversity and disturbed com-
position of the gut microbial community, not only has
an influence on the occurrence of asthma and allergies,
but also on other chronic and relapsing inflammatory
conditions that include type 1 diabetes [55], inflamma-
tory bowel disease (IBD) [56,57], obesity [42], and even
psychiatric disorders, such as depression [58]. Studies in
both mice and humans indicate that some common
members of the normal microbiota could exert a special
Haahtela et al. World Allergy Organization Journal 2013, 6:3 Page 4 of 18
http://www.waojournal.org/content/6/1/3
role in maintaining homeostasis and immune health
[29,45,56,57]. A decrease or absence of these microbes
in the colon has been shown to lead to impaired deve-
lopment of regulatory T lymphocytes (T reg cells), the
T cell subset that mediates suppression of T-cell mediated
inflammatory responses. Moreover, an imbalance of ‘pro-
inflammatory’ and ‘anti-inflammatory’ microbes may also
result in an increased susceptibility of the host to inflam-
matory diseases [29] and could explain the increase in
paediatric inflammatory bowel disease (IBD) [59], one of
the many inflammatory diseases being reported with in-
creasing frequency in westernized countries (Figure 2).
Although it is unclear what is the cause and effect, the
rich literature on the mechanisms for the development
of epithelial cell tolerance and homeostasis referred to
above and the experimental models using transfer of
gut microbiota [55,60] support the concept of alterna-
tive stable states. Altered environmental microbiota and
reduced signaling of TLR and other receptors cause im-
mune dysfunction, enhancing the colonization and growth
of a biased microbiota, thus creating a self-perpetuating
circle to push the host-microbe interaction toward an
‘unhealthy’ state [14]. Collectively, sedentary lifestyle in
affluent urban environments does not provide adequate
microbial exposure to develop ‘healthy’ microbiota, an
essential part of the immune system closely linked to
the development and maintenance of epithelial cell tol-
erance and homeostasis. An indirect illustration of this
concept is that faecal microbiota transplant has been
successfully used to restore the microbiota balance in
severe Clostridium difficile infections [61].
Skin microbiota
Skin flora, similarly to gut flora, can be viewed as a com-
munity or an organ composed of various cell lines that
communicate with each other and with host cells. The
use of global metagenomic approaches reveals that the
microbial diversity of the skin is comparable to that in
the gut [44,62], giving credence to the fact that the skin
flora is a part of the immune system and able to shape
the responses. In genetically predisposed individuals,
various environmental factors may lead to inflammatory
skin responses and impaired barrier function as seen
with chronic eczema [63]. A good example is the pos-
sible role of staphylococci in predisposing to atopic
eczema [40], but on a larger scale, the role of skin
microbiota in barrier function is not yet fully elucidated.
Several metagenomic studies [62,64-66] demonstrate
that the skin microbiota is composed mainly of members
of the same four phyla that comprise the gut microbiota,
although with dissimilar relative abundances [64-66]. An
exciting and highly relevant study shows that each of
these two body sites harbour its own characteristic
microbiota, with little temporal variation [64,65]. The
factors that determine these complex communities and
their relationship to the host both to maintain health
and predispose to disease open up a whole new field of
inquiry into human homeostasis and its potential link to
the wider environment.
As in the gastrointestinal tract, the skin microbial
community includes both transient and resident micro-
biota [66,67], suggesting that at least a part of the skin
flora is in a dynamic interaction with the environment.
To probe these interactions, long-term studies are needed
over lifetime, on the intensity and composition of the
skin flora in people living in contrasting environments
in different countries and socioeconomic conditions and
their associations with health and disease.
Effect of antibiotics
Antibiotics modulate microbiota, and the effect may be
long-term. One-week course affected the gut microbiota
even for three years [68]. Recent systematic review by
Murk et al. [69] indicated a slight increase in the risk of
asthma, if antibiotic were used during pregnancy or in
the first year of life. Hill et al. [70] showed how in anti-
biotic treated mice commensal-derived signals influenced
basophil hematopoiesis and susceptibility to TH 2 cytokine-
dependent inflammation and allergic disease. Cho et al. [71]
increased adiposity in young mice by administering sub-
therapeutic doses of antibiotics. Changes were observed in
the gut microbiota as well as in copies of key genes
involved in the metabolism of carbohydrates to short-chain
fatty acids.
Altogether, antibiotic manipulation seems to alter, es-
pecially in early-life, metabolic homeostasis and increase
risk of allergic and other inflammatory conditions.
Immigration reshaping immune regulation
Immigrant studies have provided invaluable evidence for
the immunoregulatory capacity of the living environ-
ment. When immigrants move from areas of low to high
prevalence of disease, they have a good health status at
the time of arrival (healthy immigrant effect), but this
declines thereafter and converges to that of the natives
[72] or even becomes worse. The immunomodulatory
changes appear to occur within 10 years after arrival
[72-75], and these changes are not restricted to young
people only but also occur in adults as well [76,77]. This
immunomodulation by “cultural adaptation”, which leads
to changes in disease susceptibility, appears to be universal
and has been reported for various inflammatory diseases,
including asthma and allergic diseases [74,75,77,78],
autoimmune diseases, such as type 1 diabetes [73] and
multiple sclerosis [76], obesity and type 2 diabetes [79],
depression [80] and civilization cancers [81].
Of note, this list of disorders is almost identical to the
disease spectrum associated with altered gut microbiota
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as discussed above. Recently-arrived individuals may
experience a particularly dramatic reduction in health
status, even if they are younger than the native residents
and earlier immigrants. The relatively rapid change in
health status is best explained by the dietary factors
affecting gut microbiota. In addition to dietary factors
and environmental exposures, psychological factors, such
as loss of socioeconomic status contributing to stress and
depression [72], are likely to play a key role in the immune
modulation observed in immigrants.
Additional risk factors
Air pollution
Indoor and outdoor pollution is a major environmental
risk factor for asthma and allergy not only increasing the
prevalences of long-term symptoms but also acute attacks
[82]. The association studies indicate that ambient air
pollution is connected to asthma, rhinitis, rhinocon-
junctivitis, acute respiratory infections, the need for asthma
drugs, and hospital admissions because of respiratory symp-
toms. Indoor tobacco smoke is the most obvious risk factor,
which can be reduced by legislation and education. In
Turkey a tobacco ban initiated in 2009 resulted in a 24%
decrease in respiratory emergency visits in Istanbul in
one year [83].
The main ambient air pollutants are derived from fuel
combustion (traffic and various industrial sources like
power plants and refineries). Fine particulate matter,
nitrogen and sulphur compounds (NOx, SOx) are the
most important pollutants emitted directly to the atmos-
phere. Ozone (O3) is produced by the reaction of sunlight
with air containing hydrocarbons and NOx. In China,
ambient air pollution is associated with 300 000 deaths
and 20 million cases of respiratory illnesses annually [84].
The most important sources of indoor air pollutants,
in addition to tobacco smoke are biomass fuels, like
wood and coal, for heating and cooking, cleaning and
washing products and mold/dampness. Conservative
estimates indicate that indoor air pollution may be re-
sponsible for nearly two million deaths per year in deve-
loping countries [85].
Climate change
The Intergovernmental Panel on Climate Change (IPCC)
defines climate change as a “change in the state of the
climate that can be identified (e.g. using statistical tests)
by changes in the mean and/or the variability of its
properties and that persists for an extended period, typ-
ically decades or longer. It refers to any change in cli-
mate over time, whether due to natural variability or as
a result of human activity.” The IPCC further states that
warming of our climate system is unequivocal, demon-
strated by increases in global air and ocean temperatures
in addition to widespread melting of snow and ice as
well as rising sea levels [86]. Climate change is resulting
in chemical, physical and biologic stressors that have far
reaching consequences to health [87].
The prevalence of asthma and allergic rhinitis has mark-
edly increased globally since the 1960s [88,89]. Pollen is
an important trigger in many patients with allergies and
asthma. Air pollution and higher concentrations of CO2-
induced increases in levels and allergenicity of allergenic
pollens may be contributing to increasing prevalence of
allergic disease and asthma, with climate change a plaus-
ible explanation for both [90].
Climate change has direct impacts on aeroallergens, in
particular pollens and mold spores and allergic diseases
[90-92]. Pre-Industrial CO2 levels in 1870 were 280
ppm, followed by a steady increase of 35% by 2005 to
379 ppm, with urban areas exhibiting the highest levels
[87]. Several studies have demonstrated direct correla-
tions between rising CO2 and increases in both pollen
and biomass levels, as well as increased allergenicity of
the pollen [93,94]. Ziska, et al. [94] tested the hypothesis
that ragweed pollen levels were impacted by pre-
industrial revolution CO2 level (280 ppm), current CO2
levels (370 ppm) and CO2 levels (600 ppm), projected
level for the year 2100. All variables remained constant
using a greenhouse environment, with the exception of
rising CO2 levels. There was a 132% increase in ragweed
pollen from pre-industrial to current and an additional
90% increase in pollen level at projected 2100 levels. In
the greater Baltimore area between 2000 and 2001, Ziska
demonstrated that the urban levels of CO2 were 30%
higher and temperature 2 degrees Celsius higher than
surrounding rural areas. A fundamental aspect of climate
change is the potential shift in flowering phenology and
pollen initiation associated with milder winters and
warmer seasonal air temperature. Earlier floral anthesis
has been suggested, in turn, to have a role in human dis-
ease by increasing the time of exposure to pollen that
cause allergic rhinitis and related asthma. In the urban
area, the ragweed plants produced 189% more pollen,
compared with the surrounding rural area [95].
Correlation between earlier ragweed pollen start dates,
prolonged pollination cycles and increasing latitudes of
ragweed growth in North America has also been reported,
with a nearly linear increase from Oklahoma City with
1 day earlier from 1995 to 2009 to a high of 27 days
earlier in Saskatoon, Canada [96]. In addition to increases
in pollen levels and prolonged pollination cycles, there is
also evidence of an impact on pollen spatial distribution,
dispersal of pollen and increased allergenicity of the
pollens [97,98].
D´Amato et al. [99] have described the potential of cli-
mate change to alter atmospheric circulation patterns,
which contribute to long distance transport of allergenic
pollen. Extreme events like thunderstorms and cyclones
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have an impact on aeroallergens increasing the risk of
sudden exposure.
In high CO2 environments, birch pollen exhibited
increased bet-v-1 specific IgE binding compared to
baseline levels, p<0.05 [100]. Interestingly, similar fin-
dings have been demonstrated with molds, specifically
Alternaria alternata, with a significant increase in spore
production as well as an increase in allergenicity in high
CO2 environments compared to low [92]. These effects
do not seem limited to pollen and spores. Increased to-
xicity (allergenicity) has also been demonstrated in poi-
son ivy subjected to elevated atmospheric CO2 [101].
A recent retrospective study looked at 27 years of pollen
counts compared with correlating prevalence of the deve-
lopment of allergen sensitivity. Significant increases in
pollen levels and duration of the pollen season of cypress
(+18 days), olive (+18 days) and parietaria (+85 days) were
demonstrated, with no significant change in birch or grass.
The percentage of patients sensitized to those pollens
significantly increased (p<0.05), while there was no change
in the prevalence of dust mite sensitivity (used as a con-
trol). The authors went on to look at climate variables,
finding significant correlations with rising levels and pro-
longed season with increasing temperatures and increased
solar irradiation [102].
Impact of climate change on indoor aeroallergens,
such as molds, house dust mites, cockroaches, rodents,
and others pests have received less attention than those
on outdoor allergens. For example, increased relative
humidity will increase the risk for mold growth and
heavy periodic rainfalls stress the buildings to manage
excess water flow [103].
Gene – environment interaction
Disposition to atopy and associated allergic disorders
are strongly heritable. In addition, most atopic diseases
coexist in the same patients suggesting overlapping
mechanisms that involve in large part Th2-related inflam-
matory mechanisms. Atopy that predisposes to enhanced
sensitisation to common allergens is only one genetic
factor driving the heritability of allergic disease, another
are genes that predispose to expression of the atopic
phenotype in a particular organ. A good example is atopic
dermatitis (eczema). The mutations of the filaggrin gene
may increase skin permeability and predispose to allergen
penetration and sensitisation of the skin (also upper air-
ways) and are closely associated with severe disease [104].
A breakdown of epithelial barrier function is also an emer-
ging factor in other allergic diseases such as food allergy,
rhinosinusitis and asthma although other defects beyond
filaggrin are involved [105].
The large geographic variations in the prevalence of
allergic diseases and rising trends reported in the low
and middle income countries have been linked to some
aspects of Western lifestyles, but what these factors are
have so far eluded definition. The genetic changes in
populations over the time when these trends have oc-
curred cannot account for the rise in allergic disease
associated with socioeconomic gradients. As discussed
earlier, changes in microbial exposure, diet and expos-
ure to pollutants and chemicals (not discussed further
in the present paper) are all being pursued as possibil-
ities. Most likely, it will be multiple environmental
changes interacting at different time points across the
life course (including pregnancy) that interact to predis-
pose to allergic sensitisation and atopic disease.
Although there have been many examples of genetic
mutations of pathogen recognition receptors (PRR),
especially toll-like receptors influencing the association
between atopic disease including asthma, genome- wide
association studies (GWAS) have in this respect been
disappointing [106].
This is especially the case in the protective influence of
early life microbial exposure in farming and related envi-
ronments and anthroposophic lifestyles, and novel genes
associated with asthma and atopy. The exception is expos-
ure to maternal and environmental tobacco smoke that
has been reported to increase the strength of association
between some novel genes and asthma e.g. the ORMDL3
locus on 17q21 and PCDH1 on 5q31-q33 [107]. What are
now needed are GWAS in which environmental measures
and individual responses are incorporated at the start in
order to uncover those disease-related genes that are
most sensitive to particular environmental exposures.
Another way of seeking such genes is to explore epigenetic
influences.
Epigenetic modulation
Epigenetic changes, functionally relevant, environmen-
tally induced genome modifications that can be heri-
table, but are unrelated to DNA sequence changes [108],
has received much attention over the past few years as
an explanation of immune modulation by environmental
exposure. Environmental factors are key players in
activating or silencing genes by altering DNA (CpG is-
land) and chromatin histone acetylation, methylation
and phosphorylation thereby altering chromatin struc-
ture, or through the inhibitory effects of microRNAs on
gene translation, thus modifying disease susceptibility in
individuals.
Epigenetic changes are likely to be of major impor-
tance in contributing to phenotypic expression of com-
plex disease and are highly disease- and organ- specific.
GWAS of several complex diseases have identified a
number of genetic variants, but these variants only
explain a minor part of disease susceptibility. For ex-
ample, over 45 single nucleotide polymorphisms (SNP)
associated with Type 2 diabetes account for only 10% of
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the phenotype. In the case of asthma, the EU GABRIEL
collaboration reported highly significant genome-wide
associations with loci on chromosomes-17 (ORMDL3/
GSDMB), -2 (IL1RL1/IL18R, -6 (HLA-DQ gene cluster),
-9 (IL33), -15 (SMAD3) and -22 (IL2RB) that is claimed to
account for up to 50% of asthma risk across the life course
[109]. Nevertheless, only a small proportion of the herit-
ability of asthma can be accounted for by novel genes
identified by GWAS. The missing heritability may in part
result from non-synonymous variants with high pene-
trance as has been reported in some cases of extreme
obesity.
The involvement of epigenetic changes in this ‘missing
heritability’ [108] is also apparent, but still needs to be
verified. Studies of disease discordance in monozygotic
(MZ) twins indicate that significant epigenetic modulation
occurs in utero. A study among newborn twins highlights
the importance of the intrauterine period for establishing
epigenetic variability in humans [110]. It is likely that
many factors will influence epigenetic expression of spe-
cific genes beyond disease including, but not limited to,
age, sex, shared environments, diet and smoking.
A microbe-rich environment has been shown to
induce both pro-inflammatory and regulatory circuits
very early in life [111], indicating early activation of the
relevant genes. Prenatal exposure to high levels of
microbial products e.g. milking parlours and cow sheds
is especially protective. Such exposures lead to high cir-
culating levels of Tregs, so that in mice, selective deple-
tion of Tregs during the allergen sensitisation phase
dramatically enhances experimental allergic lung inflam-
mation [112]. One study in humans has shown that
maternal cells have the capacity to traverse the placenta
and enter fetal lymph nodes to induce Tregs with sup-
pressive functions to prevent anti-maternal immunity
[113]. Recently, reduced human placental Foxp3 has
been shown to be associated with subsequent infant
development of allergic disease [114].
Further support for maternal programming to protect
against infant allergen sensitisation comes from exposing
pregnant mice to the Gram-negative, non-pathogenic
bacterium Acinetobacter lwoffii F78 found in cow sheds
and which has been shown to activate TLR2, 3, 4, 7, and
9. Combining prenatal exposure to A. lwoffii F78 with a
mouse model of Th2-mediated airway inflammation
leads to protection from development of an allergic lung
phenotype in the offspring [115,116]. The mechanism
involves up-regulation of maternal lung TLR expression,
initiation of a transient acute local Th1-like inflamma-
tory response, systemic release of inflammatory cyto-
kines and a down-regulation of TLR and cytokine
expression in the placenta. As the offspring from A.
lwoffii F78-treated TLR2/3/4/7/9−/−mothers were no
longer protected from Th2-type airway responses to
inhaled antigen, maternal TLR signalling appears crucial
for mediating the transfer of this transgenerational pro-
tective effect. Most recently, the inhibitory effect of A.
lwoffii F78 on the development of an allergic lung
phenotype in the offspring has been shown to be IFN-γ
-dependent and epigenetically controlled through chro-
matin histone 4 (H4) acetylation of the IFNG promoter
of CD4+ T cells with inhibition of H4 acetylation abo-
lishing the Th2-protective phenotype [117,118].
Traffic-related air pollution is an example of an envi-
ronmental factor that may increase disease susceptibility
due to epigenetic changes. A study among school chil-
dren with and without asthma living in areas with
contrasting levels of ambient air pollution showed that
pollution is associated with increased methylation of
CpG islands in the Foxp3 locus, reduced T reg cell func-
tion and increased asthma severity scores. A dose-
dependent relationship between the exposure to air
pollution and Treg cell function and/or Foxp3 methyla-
tion has been reported [119]. However, complete
demethylation of the regulatory regions of the Foxp3
gene is required for stable Foxp3 expression linked to
Treg cell function [120]. Traffic-related particles have
been found to exert epigenetic modulation even when
exposure occurs via the placenta [121].
Though early life is important for epigenetic modula-
tion, such changes also occur in adults [122], which is
not unexpected, given the inherent plasticity of the epi-
genetic mechanisms. This plasticity also provides for an
opportunity for environmental/behavioural strategies in
disease prevention [123].
Although the imbalance in regulatory versus inflam-
matory circuits is a universal feature in various inflam-
matory conditions, the basic mechanisms have been
examined in greatest detail in allergic diseases, the focus
of the following discussion.
Tolerance – the key issue in allergy prevention
The concept of induction of immune tolerance has
become a prime target for prevention and treatment
strategies for many diseases such as allergy, asthma,
autoimmunity, organ transplantation and infertility in
which dysregulation of the immune system plays an
essential role. In addition to various modes of allergen-
SIT, healthy immune response development during high
dose of allergen exposure in beekeepers and cat owners
have been intensively studied to understand mechanisms
of allergen tolerance in humans [124,125]. Mechanisms
include changes in the profile of allergen-specific me-
mory T and B cell responses, and specific antibody iso-
types towards a non inflammatory direction, as well as
decreased activation, tissue migration and degranulation
of mast cells, basophils and eosinophils [10,126,127].
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In different guidelines and consensus reports little
attention is devoted to immunological tolerance and
how to strengthen this in the prevention and manage-
ment of allergic diseases. This is the case in spite of the
fact that basic immunological mechanisms of tolerance
have largely been unravelled and the commonly used
strategy to reduce allergen exposure at different stages
from the inception of an allergic disease to its life-long
expression (allergen avoidance) is of questionable effi-
cacy. With the possible exception of occupational expo-
sures, effective allergen avoidance is difficult, if not
impossible, and the results from the avoidance trials
have been mostly discouraging [128,129]. Although there
is some evidence that multiple allergen reduction strat-
egies are more successful, at least for primary prevention
[130], complex and multifaceted avoidance procedures
cannot be seen as a long term solution for a common
public health problem [131].
It has been generally thought that the dose-response
curve for gaining immunological tolerance to different
allergens/ bioparticles is different. However, the emer-
ging picture is that a non-linear bell-shaped dose-
response curve is a universal phenomenon, shown at
least for endotoxin, fungal 1-3-beta-glucans, cat and dog
allergens, rat and mouse allergens and house dust mite
allergens (reviewed in [128]). In several recent reviews,
the mechanisms in the development of tolerance have
been comprehensively considered [132-134].
Clinical tolerance in its broadest terms comprises
not only immunological tolerance, but also tolerance
affecting tissues and cells other than the immune sys-
tem, including psychological tolerance. Mild, intermit-
tent allergy can be viewed as a trait or characteristic
rather than a state requiring regular treatment or strict
instructions for allergen avoidance. Mild allergy does
not necessarily worsen with time [135], but often, par-
ticularly in children, wanes naturally through child-
hood and adolescence.
Practical actions to promote allergy health
There are no clearly established guidelines for primary
prevention of allergic disease or any established methods
to non-specifically strengthen tolerance in established
disease. However, data have accumulated to indicate that
some simple behavioral activities can confer some pro-
tection against or alleviate allergic diseases, providing
indirect evidence of their beneficial effects on tolerance.
Not unexpectedly, such interventions include physical
exercise, a healthy diet and connection with the natural
world and countryside. Acting in synergy with specific
immunotherapy, enhancing tolerance by these means is
important also in secondary prevention (Figure 3).
In Western societies, chronic inflammatory diseases
affect an increasing proportion of the population. In pre-
vention and disease management, studies that highlight
the immunological and anti-inflammatory effects of
environmental- and life-style factors are urgently needed,
particularly in view of this increased inflammatory bur-
den (Tables 2, 3).
Physical activity
Several outlines of evidence emphasize the risks of a
sedentary lifestyle for health. Physical inactivity increases
the inflammatory burden, independently of obesity, and,
conversely, exercise programs decrease systemic low-
level inflammation in various patient groups and healthy
adults (reviewed in [136]). The anti-inflammatory effects
of physical exercise seem to be mediated by activating
the regulatory circuits, including regulatory T cells. For
example, in healthy adults, a 12 week program of mode-
rate exercise 3 times per week significantly improved
regulatory T cell numbers and function [137]. Moderate
exercise for 12 weeks in patients with type 2 diabetes,
significantly decreased HbA1c levels while increasing
IL-12 levels and the expression of transcription factors
T-bet and Fox3p+, indicating improvements both in the
metabolic and the immune systems [138]. In asthmatic
T cells
B cells
• SLIT
• SIT
NKT NK
DCs, macrophages,
monocytes, neutrophils,
mast cells, eosinophils, basophils
• Healthy diet
• Probiotics
• Physical exercise
• Connection
   with nature
Acquired immunity
• specific
• memory
• rearranged receptors
Innate immunity
• unspecific
• no conventional memory
• germline-encoded receptors
Figure 3 Tolerance can be endorsed by behavioral means including physical training, consumption of healthy diet and doing activities
in natural environments. These things should be included also in secondary prevention together with specific immunotherapy. Unspecific and
specific means to endorse tolerance act in synergy. Natural Killer (NK) cells and Natural Killer T (NKT) cells share characteristics of both innate and
acquired immunity. SIT=Specific Immunotherapy, SLIT=Specific Oral Immunotherapy.
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children, a 12-week exercise program decreased total-
and house dust mite specific IgE levels [139]. The
anti-inflammatory effect of exercise has also been
demonstrated in a murine model of asthma [140]. Phys-
ical activity is an especially important means for primary
allergy prevention in children. In particular, children
with asthma benefit from moderate physical activity, as
they have frequently been found to be more inactive
than their non-asthmatic peers [141].
Healthy diet
In addition to micro-organisms, dietary factors have
been extensively studied to uncover possible additional
factors behind the asthma and allergy epidemics in mo-
dern urban environments, given the modulatory poten-
tial of nutrients on epigenetics, intestinal microbiota and
immune function [142]. While an inverse link between
various nutrients or vitamins and occurrence of allergic
diseases has been proposed in cross-sectional studies,
the results are inconsistent and inconclusive. However, a
systematic review based on 62 reports and 11 databases
concludes that although the epidemiologic evidence thus
far is weak, it supports a beneficial role for increased
consumption of more fruits and vegetables, associated
with better asthma and allergy outcomes. For example, a
traditional Mediterranean diet confers protection against
persistent wheeze and atopy [143]. It must be also born
in mind that at least a part of the beneficial effect of
fresh fruit and vegetables may be mediated by micro-
organisms abundantly present on their surfaces [144].
Vitamin D deficiency has been suspected to play a role
in the ´asthma epidemic´ as it may influence genomic pro-
gramming of fetal development and subsequent disease
risk and is tightly linked to diet and exposure to sunlight.
This hypothesis is in the process of being tested in a large
controlled trial in pregnant women and their offspring for
the primary prevention of asthma [145,146].
Altogether, little is known of the mechanisms involved
in the effects of healthy diets on the origins and progres-
sion of allergy or associated diseases. With respect to
unhealthy food and overeating, preliminary data are
available to show that obesity in mice and humans leads
to Treg cell depletion in adipose tissues which, in turn,
is associated with adipose tissue inflammation in obese
individuals [147].
Probiotics
The benefits of probiotics to prevent or treat allergic dis-
eases and asthma remain inconclusive. Bacteria-based
products hold great promise for allergy prevention, but
in the case of probiotics, the most beneficial bacterial
strains, doses, duration and timing of supplementation
are not determined [148-150]. A controlled clinical trial
of about 1000 high allergy risk infants indicates that a
probiotic mixture for 6 months has some protective
effect against IgE associated (atopic) eczema at 2 years.
This effect disappeared at 5 years, but remained in cae-
sarean section -delivered children [151]. Probably a more
or less continuous stimulation of innate immunity is
needed to build up and maintain tolerance, not only
intervention of 6 months.
Connection with nature and the natural environment
An urban environment appears to lack elements that
apparently are important for the proper development
of immune tolerance. The recognition of the (absolute)
dependence of humans on both the commensal and en-
vironmental microbiota is crucial to unravel the mechan-
isms involved. In recent years, concepts such as ‘ecotherapy’
[152], ‘green exercise’ [24] and ‘forest therapy’ [27] have
been launched. Urbanization and densification policy
continues globally, and within the next 30 years, it is
Table 2 Practical advice to build-up and improve
tolerance for primary prevention [157]
Primary prevention
• Support breastfeeding, solid foods from 4–6 months.
• Do not avoid environmental exposure unnecessarily (e.g. foods, pets).
• Strengthen immunity by increasing connection to natural environments.
• Strengthen immunity by regular physical exercise.
• Strengthen immunity by healthy diet, e.g. traditional Mediterranean or
Baltic type.
• Use antibiotics only for true need, majority of microbes are useful and
build-healthy immune function.
• Probiotic bacteria in fermented food or other preparations may
strengthen immune function.
• Do not smoke, e.g. parents smoking increase asthma risk in children.
Table 3 Practical advice to build-up and improve
tolerance for symptom prevention (secondary
prevention) and to prevent exacerbations/attacks
(tertiary prevention) [157]
Secondary and tertiary prevention
• Regular physical exercise is anti-inflammatory
• Healthy diet is anti-inflammatory, e.g. traditional Mediterranean or
Baltic type of diet improves asthma control.
• Probiotic bacteria in fermented food or other preparations may be
anti-inflammatory.
• Allergen specific immunotherapy:
- allergens as is (foods)
- sublingual tablets or drops (pollens, mites)
- subcutaneous injections (e.g. insect stings)
• Hit early and hit hard respiratory/skin inflammation with medication.
Find treatment for long-term control.
• Do not smoke, asthma and allergy drugs do not have full effects in
smokers.
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estimated that two-thirds of the world’s population and
85% of the population in the developed countries will
live in urban areas with little green space [153]. Preva-
lence of inflammatory diseases is likely to increase even
more. The health effects of nature and green spaces (see
‘Biodiversity and human health’) should be recognized,
and measures to limit excessive land use and fragmenta-
tion urgently undertaken.
Need for a global allergy plan
Success in several asthma programs in various countries
have shown that a change for the better can be achieved
with a pragmatic population-based action plan with set
goals [154,155]. For allergy, including variable conditions
from asthma to food allergy and anaphylaxis, one such
comprehensive, nationwide plan has been successful
[128,156,157]. In Finland, the allergy initiative collabo-
rated with the government (both central and local) and
several national and international organizations as well
as non-governmental patient organizations to decrease
the burden of all allergic conditions. Such an allergy
action plan is a challenging task given the multifaceted
and complex nature of the entity ‘allergy’ (Figure 4).
The rationale for such a program must stand on two
equally important pillars - the best scientific evidence
and a broad clinical experience. The goals and focus of
the plan have to target the central problems, the plan
and strategies need to be well defined and evaluation
methods defined. In order to address this escalating
major global health challenge, WAO has taken steps in
this direction with the recently published WAO White
Book on Allergy which provides a comprehensive view
of the problem, includes reports from its national
member societies about the current state of allergy/
immunology resources in their countries, and offers
recommendations for action [158].
Concluding remarks
An ever-growing proportion of populations suffer
from chronic inflammatory diseases, also called non-
communicable diseases [159], as a result of mismatched
immunological mechanisms and adaptation to modern
urban life. Environmental micro-organisms, previously
ubiquitous and abundantly present e.g. in our food,
drinking water and milk, are key players for the induc-
tion and maintenance of immunoregulatory circuits and
tolerance [11,50]. Our life-style and environment have a
constant and continuous effect on the composition and
dynamics of our microbial communities, and on the in-
nate and adaptive immunity as the result. The total
exposition matters: through gastrointestinal tract, vagina,
skin and airways.
Two independent lines of research, i) metagenomic
studies of the gut microbiota (and increasingly of other
sites) and ii) immigrant studies, indicate that inflamma-
tory diseases characteristic of modern life in affluent
countries are associated with changes in the environ-
mental and indigenous microbiota. Reduced diversity
and changing composition of micro-organisms in envi-
ronments is a consequence and a part of the more global
problem of disappearing natural environments and gen-
eral loss of biodiversity. The ´far out biodiversity´ (plant
and animal life) and the ´close to biodiversity´ (micro-
biotas) are interconnected and shrinking.
Food
allergy
Anaphylaxis
Dermatitis
Rhino-
conjunctitivits
Urticaria
Drug
allergyAsthma
Other chronic
inflammatory
disorders
Allergy
long-term immune dysfunction 
and inflammation
Figure 4 A variety of age-dependent and organ specific clinical allergic manifestations - which often occur together in the same
predisposed individuals - contribute to the growing global allergy burden.
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Modern research focuses on microbiotas inhabiting
the barriers of man and environment. The genetic
composition of the barrier microbiotas, microbiomes
mediate the signalling between human DNA and envi-
ronmental DNA. It is this cross-talk, which we are only
starting to explore, that determines our survival; the
capability of the human immune system to make the
difference between danger and non-danger, and the
difference between self and non-self (Figure 5). The bar-
rier microbiomes can be regarded as the “second genetic
reservoir” of man, co-existing as a result of co-evolution
of millions of years.
Pressure caused by the ever growing human popula-
tions has direct effects through habitat destruction and
indirect effects through climate change [160]. Climate
change has the potential to increase aeroallergens such
as pollen and mold spores by earlier start of pollen sea-
son, increased allergenicity, and changes in pollen spatial
distribution. These changes adversely impact allergic
diseases.
Air pollution, both outdoors and indoors, is a severe
global problem and needs full attention. It may break
mucosal tolerance in several ways. However, even in cit-
ies with a relatively clean and controlled air, occurrence
of allergies is high, and even higher than in cities with
more air pollution problems. It is probable that poorly
developed immunological tolerance is more of a basic
factor on which many secondary factors, like air pollu-
tion, build their burden. The interactions are complex
and poorly understood.
The key question is how to maintain and restore toler-
ance in various populations, which, along with globalization,
are more movable than ever? Specific immunotherapy (SIT)
was introduced 100 years ago [161] and has evolved in
many ways. Restoration of tolerance is partly possible even
in diseased individuals. But SIT may work even better,
if the mechanisms of innate immunity are targeted
more effectively. No established means for primary pre-
vention are available, albeit bacteria-based products
hold some promise.
The Global Allergy Plan could be a powerful tool to in-
crease awareness of the global public health problem and
combat the high burden of allergies. It may also have a
preventive effect on other non-communicable diseases.
The biodiversity hypothesis can be regarded as an
extension of hygiene [162,163] or “old friends” hypothesis
[1,11] and microbial deprivation or microbiota hypothesis
[164]. Population growth (urbanization) leads to loss of
biodiversity (poor macrobiota/microbiota), poor human
microbiota (dysbiosis), immune dysfunction (poor toler-
ance), inflammation and finally to clinical disease.
Definition of terms
Biodiversity The variability among living organ-
isms from all sources, including,
inter alia, terrestrial, marine and
other aquatic ecosystems and the
ecological complexes of which they
are part this includes diversity within
species, between species and of
ecosystems
Commensal A member of the normal flora
Dysbiosis Reduced diversity and disturbed com-
position of the microbial community
within a given niche
Epigenetic changes Functionally relevant genome mod-
ifications, induced by environmen-
tal stimuli, that can be heritable,
but are unrelated to DNA sequence
changes
Indigenous Within the person (synonymous to
‘commensal’ flora)
Human cell
DNA
Barrier
microbiome DNA
(gut, skin, airways)=
mediators between
environment
and man
Environmental
DNA
Figure 5 The interactions, “cross-talk” of the three cellular DNA compartments determines human survival.
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Macrobiota The living organisms of a region
that are large enough to be seen
with the naked eye.
Metagenomic Refers to all of the genetic material
of a microbial community sequenced
together.
Microbiome All of the genetic material of micro-
organisms within a given niche.
Usually refers to bacteria but can
include also genomes of fungi, viruses
and protozoans
Microbiota The assemblage of micro-organisms
within a given niche. Usually refers
to bacteria, but can include also
fungi, viruses and protozoans
Saprophyte A non-pathogenic environmental
bacterium dependent on degrading
plant material
Note
Reference [165]; see the legend of Figure 1.
References [166-168]; see the legend of Figure 2.
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